Clinical Trial Update: Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vorinostat for efficacy and tolerability in advanced, metastatic soft tissue sarcoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Heidelberg University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED